Published: 14 May 2024
Author(s): Qian Wang, Hui Dong, Hong-Wu Li, Yu-Bao Zou, Xiong-Jing Jiang
Section: Letter to the Editor

Takayasu arteritis (TA), also known as aortoarteritis, often involves the middle aorta and manifests as middle aortic syndrome (MAS) [1]. Owing to persistent and severe hypertension attributed to aortic obstruction, patients with MAS caused by TA (TA-MAS) may develop ventricular hypertrophy. Moreover, patients with TA-MAS may even progress to heart failure (HF) [2], which has an incidence of 22.9 % [3]. Pharmacological based interventional therapy is commonly used to treat TA-MAS. However, few clinical studies have examined whether this strategy can stop or reverse ventricular hypertrophy and HF.

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness